<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03981900</url>
  </required_header>
  <id_info>
    <org_study_id>A3921313</org_study_id>
    <secondary_id>DeFacTo</secondary_id>
    <nct_id>NCT03981900</nct_id>
  </id_info>
  <brief_title>IDentification of Factors Predictive of Tofacitinib's Survival in Patient With Rheumatoid Arthritis</brief_title>
  <official_title>IDentification of Predictive Factors of Continuation of Treatment With Tofacitinib in Patients With Rheumatoid Arthritis in Common Practice and the Impact of the Patient's Behavioural Strategies on Clinical Parameters: The DeFacTo Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Pfizer</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Pfizer</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Regarding Tofacitinib, newly introduced on the market, few data on drug retention and no data
      on the factors predictive of Tofacitinib drug survival in patients with RA are available.

      Therefore, the primary objective of the DeFacTo study will be to identify the factors
      predictive of Tofacitinib drug survival in patients with RA.

      As secondary objectives, the impact of behavioural strategies on drug survival and other
      clinical parameters as well as Tofacitinib effectiveness and tolerability will be studied
      under real-life conditions of use in French patients with RA.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is an observational, open-label, prospective, multi-centre, national study designed to
      evaluate the factors predictive of Tofacitinib's survival in patients with rheumatoid
      arthritis

      If catastrophisation is described as a distortion of the perception of pain involving a both
      emotional and cognitive component, pushing the patient to see only the worst, coping involves
      adaptive strategies by which the patient attempts to find solutions in order to better cope
      with his/her disease. It has been demonstrated that such behavioural strategies can influence
      directly or indirectly the intensity of symptoms in patients suffering from chronic disease.

      Therefore, as secondary objectives, the impact of behavioural strategies on drug survival and
      other clinical parameters as well as Tofacitinib effectiveness and tolerability will be
      studied under real-life conditions of use in French patients with RA.

      The duration of this study will be approximately 48 months including a 24-month recruitment
      period and a 24-month patient follow-up period.

      Patients will be followed prospectively and follow-up visits will be conducted after the
      initial consultations. No visit or additional test is required by the protocol, since the
      study is observational
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 4, 2019</start_date>
  <completion_date type="Anticipated">January 31, 2023</completion_date>
  <primary_completion_date type="Anticipated">January 31, 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Duration of Tofacitinib survival</measure>
    <time_frame>24 months</time_frame>
    <description>Tofacitinib maintenance will be estimated by considering the date of initiation of treatment with Tofacitinib and the date of permanent discontinuation of this same treatment.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in catastrophising behaviour adopted by the participant</measure>
    <time_frame>Baseline, month 1, 3, 6, 12, 18 and 24</time_frame>
    <description>Evaluate by the change from baseline of the PCS-Pain Catastrophising Scale at different time point</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in coping adaptative strategy adopted by the participant</measure>
    <time_frame>Baseline, month 1, 3, 6, 12, 18 and 24</time_frame>
    <description>Evaluate by the change from baseline of the CSQ-Coping Strategies Questionnaire score at different time point</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of participants with low disease activity (LDA)</measure>
    <time_frame>Month 1, 3, 6, 12, 18 and 24</time_frame>
    <description>Low disease activity assessed by DAS28-4 ESR/CRP &lt; 3.2, SDAI ≤ 11, CDAI ≤ 10</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of participants in remission</measure>
    <time_frame>Month 1, 3, 6, 12, 18 and 24</time_frame>
    <description>Remission assessed by DAS28-4 ESR/CRP &lt; 2.6, SDAI ≤ 3.3, CDAI ≤ 2.8, ACR-EULAR 2011 Boolean criteria (TJC ≤ 1 + SJC ≤ 1 + CRP ≤ 1 mg/dL + VAS patient ≤ 1 cm)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in score DAS28 ESR/CRP and in its components over time</measure>
    <time_frame>Baseline, Month 1, 3, 6, 12, 18 and 24</time_frame>
    <description>DAS28 ESR/CRP score and in its components over time</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluation of response to treatment considering outcome of the DAS28 (EULAR criteria)</measure>
    <time_frame>Month 1, 3, 6, 12, 18 and 24</time_frame>
    <description>Response to treatment evaluated by the DAS28 UELAR criteria</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in the number of painful joints (TJC) over time</measure>
    <time_frame>Baseline, Month 1, 3, 6, 12, 18 and 24</time_frame>
    <description>Number of painful joint count scored between 0 to 28</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in the number of swollen joints (SJC) over time</measure>
    <time_frame>Baseline, Month 1, 3, 6, 12, 18 and 24</time_frame>
    <description>Number of swollen joint count scored between 0 to 28</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluation of the possible existence of fibromyalgia</measure>
    <time_frame>Baseline, month 1, 3, 6, 12, 18 and 24</time_frame>
    <description>Fibromyalgia evaluated by the FiRST questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in the duration of morning stiffness over time</measure>
    <time_frame>Baseline, month 1, 3, 6, 12, 18 and 24</time_frame>
    <description>Moring stiffness scored in minutes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in patient compliance over time (GIRERD Questionnaire)</measure>
    <time_frame>Baseline, Month 1, 3, 6, 12, 18 and 24</time_frame>
    <description>Compliance measured by the GIRERD questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in overall health status over time (EuroQoL EQ-5D-3L questionnaire)</measure>
    <time_frame>Baseline, Month 1, 3, 6, 12, 18 and 24</time_frame>
    <description>Health status evaluated by the EuroQoL EQ-5D-3L questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in quality of life over time</measure>
    <time_frame>Baseline, Month 1, 3, 6, 12, 18 and 24</time_frame>
    <description>Quality of life over time evaluated by the SF-12 questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in fatigue over time</measure>
    <time_frame>Baseline, Month 1, 3, 6, 12, 18 and 24</time_frame>
    <description>Fatigue scored by the FACIT-Fatigue questionnaire</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Arthritis, Rheumatoid</condition>
  <arm_group>
    <arm_group_label>Rheumatoid arthritis</arm_group_label>
    <description>All participants with a diagnosis of moderate to severe active rheumatoid arthritis and treated with Tofacitinib</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Tofacitinib</intervention_name>
    <description>5 mg BID, oral administrtaion</description>
    <arm_group_label>Rheumatoid arthritis</arm_group_label>
    <other_name>Xeljanz</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with a diagnosis of moderate to severe active rheumatoid arthritis for whom the
        rheumatologist has decided to initiate a treatment with Tofacitinib
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient 18 years of age or older

          -  Patient in whom the diagnosis of moderate to severe active rheumatoid arthritis has
             been confirmed by a rheumatologist

          -  Patient for whom the rheumatologist decides to initiate treatment with Tofacitinib

          -  Patient informed and consented to participate to the study

        Exclusion Criteria:

          -  Patient participating in a randomised clinical trial.

          -  Patient presenting with a contraindication to prescription of Tofacitinib

          -  Patients who are investigational site staff members or patients who are Pfizer
             employees directly involved in the conduct of the trial.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pfizer CT.gov Call Center</last_name>
    <role>Study Director</role>
    <affiliation>Pfizer</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Pfizer CT.gov Call Center</last_name>
    <phone>1-800-718-1021</phone>
    <email>ClinicalTrials.gov_Inquiries@pfizer.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Centre Hospitalier D'arras</name>
      <address>
        <city>Arras Cedex</city>
        <zip>62022</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Cabinet Medical</name>
      <address>
        <city>Aurillac</city>
        <zip>15000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier D Auxerre</name>
      <address>
        <city>Auxerre</city>
        <zip>89011</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Cabinet Medical</name>
      <address>
        <city>Bayonne</city>
        <zip>64100</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Institut Calot Helio Marin</name>
      <address>
        <city>Berck Sur Mer</city>
        <zip>62600</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier de Fleyriat</name>
      <address>
        <city>Bourg en Bresse</city>
        <zip>01012</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Cabinet Medical</name>
      <address>
        <city>Brest</city>
        <zip>29200</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Cabinet Medical</name>
      <address>
        <city>Brive La Gaillarde</city>
        <zip>19100</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Jean Rougier</name>
      <address>
        <city>Cahors</city>
        <zip>46005</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Jean Rougier</name>
      <address>
        <city>Cahors</city>
        <zip>46005</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Infirmerie Protestante de Lyon</name>
      <address>
        <city>Caluire et Cuire</city>
        <zip>69641</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hopital Pierre Nouveau</name>
      <address>
        <city>Cannes</city>
        <zip>06414</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier de Carcassonne</name>
      <address>
        <city>Carcassonne</city>
        <zip>11010</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hopital Trousseau</name>
      <address>
        <city>Chambray Les Tours</city>
        <zip>37171</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hopital Gabriel Montpied</name>
      <address>
        <city>Clermont Ferrand</city>
        <zip>63003</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier de Compiegne</name>
      <address>
        <city>Compiegne</city>
        <zip>60321</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Sud Francilien</name>
      <address>
        <city>Corbeil Essonnes</city>
        <zip>91106</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hopital Victor Jousselin</name>
      <address>
        <city>Dreux</city>
        <zip>28102</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier des Deux Vallees Juvisy</name>
      <address>
        <city>Juvisy sur orge</city>
        <zip>91265</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Cabinet Medical</name>
      <address>
        <city>La Battie Vieille</city>
        <zip>05000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Cabinet Medical</name>
      <address>
        <city>La Moutonne</city>
        <zip>83260</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Departemental Vendee Les Oudairies</name>
      <address>
        <city>La Roche Sur Yon</city>
        <zip>85925</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hopital Suburbain</name>
      <address>
        <city>Le Bouscat</city>
        <zip>33491</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hopital B Roger Salengro-chu De Lille</name>
      <address>
        <city>Lille Cedex</city>
        <zip>59037</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire de Lille - Hopital B Roger Salengro</name>
      <address>
        <city>Lille</city>
        <zip>59037</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hopital Dupuytren</name>
      <address>
        <city>Limoges</city>
        <zip>87042</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Cabinet Medical</name>
      <address>
        <city>Limoges</city>
        <zip>87100</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Clinique de La Sauvegarde / Cabinet Le Trait D Union</name>
      <address>
        <city>Lyon</city>
        <zip>69009</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Clinique du Pont de Chaume</name>
      <address>
        <city>Montauban</city>
        <zip>82000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier de Montauban</name>
      <address>
        <city>Montauban</city>
        <zip>82013</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Montceau Les Mines-Hopital Jean Bouveri</name>
      <address>
        <city>Montceau Les Mines</city>
        <zip>71307</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hopital Jacques Monod</name>
      <address>
        <city>Montivilliers</city>
        <zip>76290</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Cabinet Medical Saint Roch</name>
      <address>
        <city>Montpellier</city>
        <zip>34070</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Clinique Beau Soleil</name>
      <address>
        <city>Montpellier</city>
        <zip>34070</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hopital Lapeyronie</name>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Orleans-Hopital La Source</name>
      <address>
        <city>Orleans</city>
        <zip>45067</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Cabinet Medical</name>
      <address>
        <city>Paris</city>
        <zip>75008</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hopital Cochin</name>
      <address>
        <city>Paris</city>
        <zip>75679</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier de Perigueux</name>
      <address>
        <city>Perigueux</city>
        <zip>24019</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospices Civils de Lyon - Hopital Lyon Sud- Hematologie</name>
      <address>
        <city>Pierre Benite Cedex</city>
        <zip>69495</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Cabinet Medical</name>
      <address>
        <city>Poitiers</city>
        <zip>86000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier La Miletrie</name>
      <address>
        <city>Poitiers</city>
        <zip>86021</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hopital Victor Provo</name>
      <address>
        <city>Roubaix</city>
        <zip>59100</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hopital Charles Nicolle</name>
      <address>
        <city>Rouen</city>
        <zip>76031</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire La Reunion Site Felix Guyon</name>
      <address>
        <city>Saint Denis</city>
        <zip>97400</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Cabinet Medical</name>
      <address>
        <city>Saint Lo</city>
        <zip>50000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hopital Inter-armees Begin</name>
      <address>
        <city>Saint Mande</city>
        <zip>94163</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire Saint Pierre</name>
      <address>
        <city>Saint Pierre</city>
        <zip>97410</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire Saint Etienne Hopital Nord</name>
      <address>
        <city>Saint Priest En Jarez</city>
        <zip>42277</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier de Bigorre Site La Gespe</name>
      <address>
        <city>Tarbes</city>
        <zip>65013</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Clinique Medipole Garonne</name>
      <address>
        <city>Toulouse</city>
        <zip>31036</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hopital Purpan</name>
      <address>
        <city>Toulouse</city>
        <zip>31059</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Cabinet Medical</name>
      <address>
        <city>Toulouse</city>
        <zip>31400</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Cabinet de Rhumatologie</name>
      <address>
        <city>Tours</city>
        <zip>37000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Cabinet Medical</name>
      <address>
        <city>Tours</city>
        <zip>37000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hopital des Hauts Clos</name>
      <address>
        <city>Troyes</city>
        <zip>10003</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Cabinet Medical</name>
      <address>
        <city>Valenciennes</city>
        <zip>59322</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hopital Psv</name>
      <address>
        <city>Villeneuve Sur Lot</city>
        <zip>47305</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Cabinet Medical</name>
      <address>
        <city>Vincennes</city>
        <zip>94300</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <link>
    <url>https://pmiform.com/clinical-trial-info-request?StudyID=A3921313</url>
    <description>To obtain contact information for a study center near you, click here.</description>
  </link>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>June 7, 2019</study_first_submitted>
  <study_first_submitted_qc>June 7, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">June 11, 2019</study_first_posted>
  <last_update_submitted>February 21, 2020</last_update_submitted>
  <last_update_submitted_qc>February 21, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 24, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arthritis</mesh_term>
    <mesh_term>Arthritis, Rheumatoid</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tofacitinib</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Pfizer will provide access to individual de-identified participant data and related study documents (e.g. protocol, Statistical Analysis Plan (SAP), Clinical Study Report (CSR)) upon request from qualified researchers, and subject to certain criteria, conditions, and exceptions. Further details on Pfizer's data sharing criteria and process for requesting access can be found at: https://www.pfizer.com/science/clinical_trials/trial_data_and_results/data_requests.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

